At close: January 8 at 4:00:01 PM EST
After hours: January 8 at 6:46:14 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-91,206.0000
-70,675.0000
-57,761.0000
-48,153.0000
-35,974.0000
Investing Cash Flow
45,088.0000
-53,646.0000
-5,403.0000
42,796.0000
-117,179.0000
Financing Cash Flow
23,656.0000
125,969.0000
72,788.0000
609.0000
149,812.0000
End Cash Position
24,744.0000
34,899.0000
33,269.0000
23,670.0000
28,394.0000
Interest Paid Supplemental Data
--
2,347.0000
170.0000
--
--
Capital Expenditure
-150.0000
-298.0000
-410.0000
-397.0000
-568.0000
Issuance of Capital Stock
10,438.0000
85,647.0000
56,137.0000
--
149,610.0000
Issuance of Debt
12,500.0000
40,000.0000
4,050.0000
--
--
Free Cash Flow
-91,356.0000
-70,973.0000
-58,171.0000
-48,550.0000
-36,542.0000
12/31/2020 - 7/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNGX Tango Therapeutics, Inc.
3.2300
-6.92%
STOK Stoke Therapeutics, Inc.
8.96
-3.76%
CMMB Chemomab Therapeutics Ltd.
2.2200
-1.77%
LRMR Larimar Therapeutics, Inc.
3.7900
-4.29%
ALEC Alector, Inc.
1.8800
-5.05%
RZLT Rezolute, Inc.
5.21
-4.05%
ORIC ORIC Pharmaceuticals, Inc.
8.50
-7.81%
OLMA Olema Pharmaceuticals, Inc.
5.75
+9.73%
ATYR aTyr Pharma, Inc.
3.7400
-3.86%
NUVL Nuvalent, Inc.
78.25
-2.33%